Weekly Versus Three-week Chemoradiation in Patients With Advanced Cervical Cancer
Status:
Completed
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Three weekly cisplatin based chemoradiation is to be compared the compliance, toxicity, and
response rates with the weekly cisplatin based chemoradiation in the treatment of
locoregionally advanced cervical cancers.